Karyopharm Therapeutics Inc. - COM (KPTI)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
59.3M
Holdings value Q3 2024
$49.2M
Value change Q3 2024
-$6.33M
Grand Portfolio weight change Q3 2024
0%
Number of holders
89
Number of buys Q3 2024
28
Number of sells Q3 2024
-59
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 59.3M $49.2M -$6.33M $0.83 90
2024 Q2 67.5M $58.6M -$7.65M $0.87 114
2024 Q1 74.7M $113M +$4M $1.51 112
2023 Q4 73.3M $63.4M -$4.57M $0.87 119
2023 Q3 76.2M $102M -$10.7M $1.34 116
2023 Q2 80.4M $144M -$18.6M $1.79 133
2023 Q1 87.6M $340M -$32.8M $3.89 127
2022 Q4 98.4M $334M +$100M $3.40 151
2022 Q3 66.7M $364M -$1.4M $5.46 141
2022 Q2 67.1M $303M -$6.91M $4.51 144
2022 Q1 68.3M $502M +$108M $7.37 135
2021 Q4 54.2M $347M -$3.38M $6.43 139
2021 Q3 57.4M $334M -$25.8M $5.82 130
2021 Q2 59M $609M -$13.9M $10.32 148
2021 Q1 59.2M $622M -$49.1M $10.52 162
2020 Q4 63.8M $988M -$54.5M $15.48 164
2020 Q3 65.1M $951M -$110M $14.60 155
2020 Q2 69.7M $1.32B +$45.2M $18.94 155
2020 Q1 68M $1.31B +$217M $19.21 140
2019 Q4 59M $1.13B -$54.7M $19.17 150
2019 Q3 58.5M $563M +$83.5M $9.62 107
2019 Q2 51.2M $306M +$3.41M $5.99 103
2019 Q1 51.2M $300M -$24.7M $5.84 104
2018 Q4 51.4M $482M +$75.2M $9.37 116
2018 Q3 43.3M $737M -$818K $17.03 118
2018 Q2 43.4M $737M +$217M $16.99 109
2018 Q1 30.9M $415M +$174K $13.42 89
2017 Q4 31M $298M +$20.3M $9.60 88
2017 Q3 28.7M $316M +$10.8M $10.98 75
2017 Q2 27.6M $250M +$5.86M $9.05 72
2017 Q1 26.8M $345M +$45.3M $12.84 80
2016 Q4 25.5M $239M +$20.2M $9.40 86
2016 Q3 23.1M $225M +$31.5M $9.73 75
2016 Q2 20M $135M -$8.39M $6.71 74
2016 Q1 21.2M $189M -$5.33M $8.92 75
2015 Q4 21.6M $286M -$24.1M $13.25 86
2015 Q3 23.5M $248M -$6.56M $10.53 89
2015 Q2 22.4M $610M +$40.4M $27.21 89
2015 Q1 20.8M $636M +$53.5M $30.61 84
2014 Q4 18.6M $698M +$49.3M $37.43 80
2014 Q3 16.8M $588M +$52.8M $34.94 71
2014 Q2 15.1M $703M +$235M $46.55 77
2014 Q1 10.1M $311M +$33.6M $30.89 59